BioSpace is launching an IPO dashboard to help the industry keep tabs on U.S. biotechs that have taken the public plunge in 2026.

The European Commission approved Germany’s financial support after assessing the risks of Sanofi stopping insulin API production at the Frankfurt campus.

EyePoint is initiating a strategic review after duravyu failed another Phase 3 trial in wet age-related macular degeneration. Amid significant layoffs and trial terminations, the company is shifting attention to the asset’s potential in diabetic macular edema.

Silence Therapeutics’ lead siRNA asset for the rare blood cancer polycythemia vera has been earning analyst raves in a tight race to challenge Takeda in a potential $2 billion market.

Unos científicos han ideado y probado una nueva estrategia para acelerar una de las etapas más complejas del proceso de descubrir nuevos fármacos, reduciendo además sus costes.   La nueva metodología es obra de un equipo internacional integrado, entre otros, …

AbbVie’s next-gen dual-targeting therapy elicited higher rates of remission than its IL-23 inhibitor Skyrizi in a Phase 2a trial of Crohn’s disease, leading analysts to wonder if the blockbuster can be outdone.

Drugmakers want a say in court to defend a rebate pilot in the 340B discount program that hospitals are trying to stop.

Unos científicos han desarrollado un nuevo tejido de algodón autodesinfectante que es capaz de eliminar bacterias, hongos y virus en hospitales y entornos comparables, mediante luz visible.   El producto es obra de un equipo del campus de Alcoy de la Universidad Politécni …

Roche is offering $400 million upfront and over $15 billion in biobucks to team up with Hansoh Pharmaceutical in hopes of developing a portfolio of new antibody-drug conjugates using the latter’s in-house tech.

Un nuevo estudio, que sin duda generará fuertes polémicas, relaciona un alto consumo de alimentos ultraprocesados con un mayor riesgo de sufrir lo que se conoce como derrames cerebrales silenciosos, pequeñas lesiones cerebrales que suelen pasar inadvertidas pero que incrementan …

The new policy signals an escalation by the Chinese government on biopharma deals but is unlikely to have a major impact given that the vast majority of foreign interest in Chinese biotech comes in the form of licensing agreements.

Unos científicos han diseñado y probado una singular batería que genera electricidad a partir de la actividad de ciertas bacterias en presencia de aguas residuales comunes.   El avance es obra de un equipo integrado, entre otros, por Seokheun “Sean” Choi y Ruo …

Novartis will continue to study Fabhalta in other indications, with late-stage studies in two rare diseases—atypical haemolytic uraemic syndrome and generalized myasthenia gravis—expected to read out later this year and next year, respectively.

Una llamativa estructura cósmica cuya forma recuerda a un símbolo de notación musical, concretamente la clave de sol, ha sido objeto de una minuciosa investigación, finalizada recientemente, y sus resultados revelan el mecanismo por el cual se generó esa caprichosa …

As the closely watched screening test moves closer to Food and Drug Administration approval, MedTech Dive asked cancer experts what encourages and concerns them most about Galleri.

The proposed changes would implement key healthcare provisions in a government funding package from February. The brunt of the reforms would go into effect in 2028.

With Twiist already available in Type 1 diabetes, Sequel has made the automated insulin delivery system available for the Type 2 population.

Disc Medicine’s bitopertin—rejected by the FDA in February—significantly reduced levels of a key disease biomarker and significantly increased the time patients with erythropoietic protoporphyria were able to spend in the sun and artificial light.

In the wake of a successful IPO and strong stock growth throughout the year, Veradermics now has late-stage data to support a regulatory package for its hair loss pill.

  Pexels     Una cuenta atrás no vende un producto: vende la amenaza de quedarse fuera, y ahí reside casi todo su poder. Las promociones por tiempo limitado funcionan porque explotan un rasgo antiguo del cerebro humano, esa tendencia a valorar más lo que est …

Learn about the strategies health systems are implementing to fix fragmented spend.

AI is becoming standard across EHRs. Here are three things healthcare leaders should consider when evaluating whether it’s truly integrated. 

Agentic AI assists with routing urgent scans, cutting minutes to treatment.

How AI-powered payer intelligence prevents denials before they happen — and why you need it now.